Texas Capital Bancshares (TCBIO) Revenue (2010 - 2026)

Texas Capital Bancshares (TCBIO) has reported Revenue for 17 consecutive years, with $324.0 million the latest figure, recorded in Q1 2026.

• Revenue for Q1 2026 came in at $324.0 million, up 15.51% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 billion (up 35.84% YoY), and the FY2025 annual result was $1.3 billion, up 34.69% from the prior year.
• Revenue was $324.0 million for Q1 2026 at Texas Capital Bancshares, down from $327.5 million in the prior quarter.
• Over five years, Revenue peaked at $525.3 million in Q4 2022 and troughed at $125.3 million in Q3 2024.
• Average Revenue over 5 years is $283.1 million, with a median of $278.0 million recorded in 2023.
• Year-over-year, Revenue slumped 55.07% in 2024 and soared 171.56% in 2025.
• Over 5 years, Revenue stood at $525.3 million in 2022, then plunged by 53.2% to $245.8 million in 2023, then gained by 15.39% to $283.7 million in 2024, then climbed by 15.44% to $327.5 million in 2025, then retreated by 1.07% to $324.0 million in 2026.
• Per Business Quant data, the three most recent Revenue figures were $324.0 million in Q1 2026, $327.5 million in Q4 2025, and $340.4 million in Q3 2025.